Skip to main content
Back
Watch Compare

ETHEMA HEALTH Corp

Data quality: 100%
GRST
OTC Services Health Services
$0.00
$0.00 (0.00%)
Mkt Cap: 2.32 M
Price
$0.00
Mkt Cap
2.32 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue grew 105.26% annually over 5 years — strong growth
Earnings declined -315.21% over the past year
Negative free cash flow of -550,338.0
Revenue growth is decelerating — 1Y growth trails 5Y average by 92.68%
Capital efficient — spends only 0.87% of revenue on capex
ROIC of 0.02% — low return on invested capital

Growth

Revenue Growth (5Y)
105.26%
Above sector avg (3.99%)
Revenue (1Y)12.58%
Earnings (1Y)-315.21%
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC0.02%
Net Margin-9.34%
Op. Margin0.03%

Safety

Debt / Equity
N/A
Current Ratio0.18
Interest CoverageN/A

Valuation

PE (TTM)
-1.61
Below sector avg (-1.21)
P/B RatioN/A
EV/EBITDA7.24
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (506 peers)
Metric Stock Sector Median
P/E -1.6 -1.2
P/B — 1.4
ROE % — -15.8
Net Margin % -9.3 -18.3
Rev Growth 5Y % 105.3 4.0
D/E — 0.4

Analyst Price Target

No analyst coverage available

Earnings Estimates

No forward estimates available

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12.58% Revenue Growth (3Y) 11.72%
Earnings Growth (1Y) -315.21% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 105.26% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 15.42 M Net Income (TTM) -1.44 M
ROE N/A ROA -4.87%
Gross Margin N/A Operating Margin 0.03%
Net Margin -9.34% Free Cash Flow (TTM) -550,338.0
ROIC 0.02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.18
Interest Coverage N/A Asset Turnover 0.52
Working Capital -12.15 M Tangible Book Value -15.18 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.61 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.15
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 7.24 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23.74%
Market Cap 2.32 M Enterprise Value 5.30 M
Per Share
EPS (Diluted TTM) 0.00 Revenue / Share 0.00
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.87% FCF Conversion 38.21%
SBC-Adj. FCF N/A Growth Momentum -92.68

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 6.02 M 5.34 M 4.82 M 1.94 M 338,996.0
Net Income -2.17 M 1.01 M 247,880.0 -1.54 M 3.08 M
EPS (Diluted) 0.00 — — — —
Gross Profit — — — — —
Operating Income -1.33 M -541,920.0 489,117.0 2,105.0 -163,344.0
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A 466,952.0 498,919.0 540,119.0 325,350.0 121,276.0
Interest Expense — — — -829,525.0 631,425.0
Income Tax -391,962.0 391,962.0 -112,220.0 -280,903.0 —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 12.16 M 11.52 M 6.56 M 6.55 M 3.82 M
Total Liabilities 19.62 M 17.72 M 15.40 M 16.01 M 18.45 M
Shareholders' Equity -7.46 M -6.20 M -10.10 M -10.68 M -15.73 M
Total Debt 2.58 M 680,672.0 460,534.0 122,167.0 —
Cash & Equivalents 244,771.0 68,573.0 140,757.0 48,822.0 90,500.0
Current Assets 528,758.0 403,100.0 542,896.0 271,799.0 935,152.0
Current Liabilities 9.65 M 8.30 M 13.29 M 13.52 M 13.86 M